Exposure of the French population to bisphenols, phthalates, parabens, glycol ethers, brominated flame retardants, and perfluorinated compounds in 2014-2016: Results from the Esteban study.


Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
02 2021
Historique:
received: 19 06 2020
revised: 10 12 2020
accepted: 12 12 2020
pubmed: 11 1 2021
medline: 24 4 2021
entrez: 10 1 2021
Statut: ppublish

Résumé

As part of the French Human Biomonitoring (HBM) programme, the Esteban study described, among other things, biomarkers levels of various chemicals in adults (18-74 years old) and children (6-17 years old). This paper describes the design of the study and provides, for the first time, data on the biological exposure of the general French population to a wide range of contaminants posing a threat to human health which are currently found in domestic environments. Esteban is a cross-sectional study conducted on a nationwide sample of the French general population. Exposure biomarkers of six families of contaminants deemed detrimental to adults' and children's health were measured in biological samples collected either at participants' homes by a nurse, or brought to a National Health Insurance examination centre. All participants were randomly selected (2503 adults and 1104 children). The geometric mean and percentiles of the distribution of levels were estimated for each biomarker. Most of the descriptive statistical analyses were performed taking into account the sampling design. Results provided a nationwide description of biomarker levels. Bisphenols (A, S and F), and some metabolites of phthalates and perfluorinated compounds (PFCs) (specifically, PFOS and PFOA) were quantified in almost all the biological samples analysed. Higher levels were observed in children (except for PFCs). Levels were coherent with international studies, except for bisphenols S and F, brominated flame retardants (BFRs) and parabens (with higher levels reported in the USA than in France). This study is the first to provide a representative assessment of biological exposure to domestic contaminants at the French population level. Our results show that the French general population was exposed to a wide variety of pollutants in 2014-2016, and identify the determinants of exposure. These findings will be useful to stakeholders who wish to advocate an overall reduction in the French population's exposure to harmful substances. Similar future studies in France will help to measure temporal trends, and enable public policies focused on the reduction of those chemicals in the environment to be evaluated.

Sections du résumé

BACKGROUND
As part of the French Human Biomonitoring (HBM) programme, the Esteban study described, among other things, biomarkers levels of various chemicals in adults (18-74 years old) and children (6-17 years old). This paper describes the design of the study and provides, for the first time, data on the biological exposure of the general French population to a wide range of contaminants posing a threat to human health which are currently found in domestic environments.
METHODS
Esteban is a cross-sectional study conducted on a nationwide sample of the French general population. Exposure biomarkers of six families of contaminants deemed detrimental to adults' and children's health were measured in biological samples collected either at participants' homes by a nurse, or brought to a National Health Insurance examination centre. All participants were randomly selected (2503 adults and 1104 children). The geometric mean and percentiles of the distribution of levels were estimated for each biomarker. Most of the descriptive statistical analyses were performed taking into account the sampling design.
RESULTS
Results provided a nationwide description of biomarker levels. Bisphenols (A, S and F), and some metabolites of phthalates and perfluorinated compounds (PFCs) (specifically, PFOS and PFOA) were quantified in almost all the biological samples analysed. Higher levels were observed in children (except for PFCs). Levels were coherent with international studies, except for bisphenols S and F, brominated flame retardants (BFRs) and parabens (with higher levels reported in the USA than in France).
CONCLUSION AND PERSPECTIVES
This study is the first to provide a representative assessment of biological exposure to domestic contaminants at the French population level. Our results show that the French general population was exposed to a wide variety of pollutants in 2014-2016, and identify the determinants of exposure. These findings will be useful to stakeholders who wish to advocate an overall reduction in the French population's exposure to harmful substances. Similar future studies in France will help to measure temporal trends, and enable public policies focused on the reduction of those chemicals in the environment to be evaluated.

Identifiants

pubmed: 33422968
pii: S0160-4120(20)32295-9
doi: 10.1016/j.envint.2020.106340
pii:
doi:

Substances chimiques

Environmental Pollutants 0
Ethers 0
Flame Retardants 0
Glycols 0
Parabens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106340

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Clémence Fillol (C)

Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France. Electronic address: clemence.fillol@santepubliquefrance.fr.

Amivi Oleko (A)

Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France.

Abdesattar Saoudi (A)

Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France.

Abdelkrim Zeghnoun (A)

Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France.

Alexis Balicco (A)

Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France.

Jessica Gane (J)

Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France.

Loïc Rambaud (L)

Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France.

Alain Leblanc (A)

Centre de Toxicologie du Québec (CTQ), Institut National de Santé Publique du Québec (INSPQ), Canada.

Éric Gaudreau (É)

Centre de Toxicologie du Québec (CTQ), Institut National de Santé Publique du Québec (INSPQ), Canada.

Philippe Marchand (P)

Oniris, INRAE, LABERCA Route de Gachet, Site de la Chantrerie, CS 50707, 44307 Nantes Cedex 3, France.

Bruno Le Bizec (B)

Oniris, INRAE, LABERCA Route de Gachet, Site de la Chantrerie, CS 50707, 44307 Nantes Cedex 3, France.

Valérie Bouchart (V)

LABEO, 1 Route de Rosel, Saint Contest, 14053 Caen Cedex 4, France.

Florent Le Gléau (F)

LABOCEA, 120 avenue de Rochon, CS10052, 29280 Plouzané, France.

Gaël Durand (G)

LABOCEA, 120 avenue de Rochon, CS10052, 29280 Plouzané, France.

Sébastien Denys (S)

Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH